Hong Kong Biotech Stock News

SEHK:6699
SEHK:6699Medical Equipment

Angelalign Technology (SEHK:6699) Earnings Surge Challenges Concerns Over Long Term Decline

Angelalign Technology (SEHK:6699) opened FY 2025 with first half revenue of US$161.4 million and basic EPS of US$0.09, setting up its latest earnings release against a year of sharply higher reported earnings and a stronger net profit margin. The company has seen revenue move from US$121.3 million and EPS of US$0.02 in 1H 2024 to US$150.8 million and EPS of US$0.05 in 2H 2024, while trailing twelve month EPS reached US$0.17 and net profit margin improved to 7.7%, which points to cleaner...
SEHK:2360
SEHK:2360Consumer Retailing

Best Mart 360 Holdings (SEHK:2360) Margin Decline Challenges Prior Earnings Growth Narrative

Best Mart 360 Holdings (SEHK:2360) has put fresh numbers on the table for FY 2025, with first half revenue of HK$1.44b and basic EPS of HK$0.12 setting the tone for how you will read the latest trailing 12 month trends. Over recent periods, revenue has moved from HK$1.39b in 1H FY 2024 to HK$1.41b in 2H FY 2024 and HK$1.44b in 1H FY 2025, while basic EPS tracked HK$0.12, HK$0.12 and HK$0.12 respectively, giving you a clear view of changes in top line scale and per share earnings. Against that...
SEHK:1717
SEHK:1717Food

Ausnutria Dairy (SEHK:1717) Net Margin Compression Challenges Bullish Growth Narratives

Ausnutria Dairy (SEHK:1717) has reported its FY 2025 first half results with revenue of C¥3.9b and basic EPS of C¥0.10, setting the tone for a year where profitability and scale are firmly in focus. The company has seen revenue move from C¥3.7b in the first half of FY 2024, with EPS at C¥0.08, to C¥3.9b in the first half of FY 2025 and EPS at C¥0.10, while trailing twelve month figures point to C¥7.6b of revenue and basic EPS of C¥0.15. For investors, the key question now is how these...
SEHK:2436
SEHK:2436IT

LX Technology Group (SEHK:2436) Profit Turnaround Tests Bullish Community Narratives

LX Technology Group (SEHK:2436) has opened FY 2025 with first half revenue of C¥1.1b and basic EPS of C¥0.02, alongside trailing twelve month revenue of C¥2.4b and EPS of C¥0.04 that confirm the move into profit. Over the last few reporting periods, revenue has shifted from C¥942.6m in 1H 2024 to C¥1.4b in 2H 2024 and then to C¥1.1b in 1H 2025. Net income has gone from a loss of C¥39.8m and C¥17.2m in the 2024 halves to a profit of C¥5.7m in the latest half, pointing to tighter cost control...
SEHK:3698
SEHK:3698Banks

Why Huishang Bank (SEHK:3698) Is Up 7.9% After Strong 2025 Earnings And Dividend Review

Huishang Bank Corporation Limited reported past full-year 2025 results on March 26, 2026, with net income of CNY 16,524.6 million and basic earnings per share from continuing operations of CNY 1.14, both higher than the prior year. The board also met to review these results and consider a final dividend recommendation, highlighting the direct link between earnings performance and potential shareholder returns. Next, we will examine how this earnings growth and the board’s dividend...